SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study

被引:2
|
作者
Sapronova, Krista [1 ,2 ,3 ,4 ]
Kake, Ruta [2 ]
Pavare, Jana [1 ,2 ]
Gravele, Dagne [2 ]
Sela, Ivita [1 ,2 ]
Ergle, Estere [2 ]
Isarova, Dana [1 ,2 ]
Grinberga, Zanda [2 ]
Zavadska, Dace [1 ,2 ]
机构
[1] Riga Stradins Univ, Riga, Latvia
[2] Children Clin Univ Hosp, Riga, Latvia
[3] Riga Stradins Univ, Vienibas gatve 45, LV-1004 Riga, Latvia
[4] Children Clin Univ Hosp, Vienibas gatve 45, LV-1004 Riga, Latvia
关键词
children; COVID-19; Latvia; seroprevalence; vaccination;
D O I
10.1097/MD.0000000000032795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) is a major global health concern. In contrast to adults, the course of the disease has been observed to be mild or even asymptomatic in children. It is therefore both clinically and epidemiologically important to measure the seroprevalence in children and adolescents to discern the overall morbidity of the disease and to compare these findings with similar data collected globally. We conducted a cross-sectional study between March and July of 2022 at the Children Clinical University Hospital in Riga, Latvia, to evaluate the seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Participants aged 0 to 18 years were enrolled during hospitalization for reasons other than COVID-19. The levels of SARS-CoV-2 spike protein and nucleocapsid antibodies were measured in blood samples. The possibility of transplacental antibody transport was evaluated by directly interviewing the mothers of participants aged 18 months and younger. Various demographic and epidemiological risk factors and their association with seroprevalence were analyzed. Positive SARS-CoV-2 nucleocapsid antibodies were designated the main criterion for seropositivity. Of 200 enrolled children, 173 were found to be seropositive, resulting in an overall seroprevalence of 86.5%. The highest seroprevalence was detected in children and adolescents aged 12 to 18 years. With the progression of the COVID-19 pandemic, the seroprevalence in children has increased significantly. We found that almost 1-third of seropositive children in our study population were unaware of being previously infected with SARS-CoV-2 due to an asymptomatic course of the disease. Our study findings pertaining to high seropositivity among children and adolescents might be beneficial for public authorities to adapt epidemiological strategies and prevention measures. The high seroprevalence rate reported here and in many other populations around the world suggests that COVID-19 will likely become one of the many seasonal viral infections.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study
    Sass, Marie Reeberg
    Juul, Tobias Sogaard
    Skov, Robert
    Iversen, Kasper
    Harritshoj, Lene Holm
    Sorensen, Erik
    Ostrowski, Sisse Rye
    Andersen, Ove
    Ekstrom, Claus Thorn
    Ullum, Henrik
    Nielsen, Jimmi
    Hageman, Ida
    Fink-Jensen, Anders
    [J]. PLOS ONE, 2022, 17 (03):
  • [2] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
    Ebinger, Joseph E.
    Botwin, Gregory J.
    Albert, Christine M.
    Alotaibi, Mona
    Arditi, Moshe
    Berg, Anders H.
    Binek, Aleksandra
    Botting, Patrick
    Fert-Bober, Justyna
    Figueiredo, Jane C.
    Grein, Jonathan D.
    Hasan, Wohaib
    Henglin, Mir
    Hussain, Shehnaz K.
    Jain, Mohit
    Joung, Sandy
    Karin, Michael
    Kim, Elizabeth H.
    Li, Dalin
    Liu, Yunxian
    Luong, Eric
    McGovern, Dermot P. B.
    Merchant, Akil
    Merin, Noah
    Miles, Peggy B.
    Minissian, Margo
    Nguyen, Trevor Trung
    Raedschelders, Koen
    Rashid, Mohamad A.
    Riera, Celine E.
    Riggs, Richard, V
    Sharma, Sonia
    Sternbach, Sarah
    Sun, Nancy
    Tourtellotte, Warren G.
    Van Eyk, Jennifer E.
    Sobhani, Kimia
    Braun, Jonathan G.
    Cheng, Susan
    [J]. BMJ OPEN, 2021, 11 (02): : e043584
  • [3] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Watheq Thabet Taher
    Amen A. Bawazir
    Talal A. Sallam
    Khaled Alsurimi
    [J]. BMC Infectious Diseases, 23
  • [4] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Taher, Watheq Thabet
    Bawazir, Amen A.
    Sallam, Talal A.
    Alsurimi, Khaled
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [5] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    El-Ghitany, Engy Mohamed
    Hashish, Mona H.
    Farghaly, Azza Galal
    Omran, Eman A.
    Osman, Nermin A.
    Fekry, Marwa M.
    [J]. TROPICAL MEDICINE AND HEALTH, 2022, 50 (01)
  • [6] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    Engy Mohamed El-Ghitany
    Mona H. Hashish
    Azza Galal Farghaly
    Eman A. Omran
    Nermin A. Osman
    Marwa M. Fekry
    [J]. Tropical Medicine and Health, 50
  • [7] Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
    Qutob, Nouar
    Awartani, Faisal
    Salah, Zaidoun
    Asia, Mohammad
    Abu Khader, Imad
    Herzallah, Khaled
    Balqis, Nadeen
    Sallam, Husam
    [J]. BMJ OPEN, 2021, 11 (02):
  • [8] SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
    Shields, Adrian
    Faustini, Sian E.
    Perez-Toledo, Marisol
    Jossi, Sian
    Aldera, Erin
    Allen, Joel D.
    Al-Taei, Saly
    Backhouse, Claire
    Bosworth, Andrew
    Dunbar, Lyndsey A.
    Ebanks, Daniel
    Emmanuel, Beena
    Garvey, Mark
    Gray, Joanna
    Kidd, I. Michael
    McGinnell, Golaleh
    McLoughlin, Dee E.
    Morley, Gabriella
    O'Neill, Joanna
    Papakonstantinou, Danai
    Pickles, Oliver
    Poxon, Charlotte
    Richter, Megan
    Walker, Eloise M.
    Wanigasooriya, Kasun
    Watanabe, Yasunori
    Whalley, Celina
    Zielinska, Agnieszka E.
    Crispin, Max
    Wraith, David C.
    Beggs, Andrew D.
    Cunningham, Adam F.
    Drayson, Mark T.
    Richter, Alex G.
    [J]. THORAX, 2020, 75 (12) : 1089 - 1094
  • [9] Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
    Szepfalusi, Zsolt
    Schmidthaler, Klara
    Sieber, Justyna
    Kopanja, Sonja
    Goetzinger, Florian
    Schoof, Anja
    Hoz, Jakub
    Willinger, Birgit
    Makristathis, Athanasios
    Weseslindtner, Lukas
    Stiasny, Karin
    Bohle, Barbara
    Krotka, Pavla
    Graf, Alexandra
    Frischer, Thomas
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, : 762 - 770
  • [10] SARS-CoV-2 Seroprevalence in a Berlin Kindergarten Environment: A Cross-Sectional Study, September 2021
    Bernhard, Julian
    Theuring, Stefanie
    van Loon, Welmoed
    Mall, Marcus
    Seybold, Joachim
    Kurth, Tobias
    Rubio-Acero, Raquel
    Wieser, Andreas
    Mockenhaupt, Frank
    [J]. CHILDREN-BASEL, 2024, 11 (04):